IVERIC bio Inc.

NASDAQ: ISEE · Real-Time Price · USD
39.95
0.15 (0.38%)
At close: Jul 10, 2023, 10:00 PM

IVERIC bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-189.91M -114.76M
Interest Income
2.26M 245K
Pretax Income
-185.21M -114.52M
Net Income
-175.75M -114.24M
Selling & General & Admin
72.89M 29.69M
Research & Development
117.01M 85.07M
Other Expenses
62K -10K
Operating Expenses
189.91M 114.76M
Interest Expense
2.26M n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
189.91M 114.76M
Income Tax Expense
-9.47M -284K
Shares Outstanding (Basic)
121.04M 101.87M
Shares Outstanding (Diluted)
121.04M 101.87M
EPS (Basic)
-1.45 -1.12
EPS (Diluted)
-1.45 -1.12
EBITDA
-192.28M -114.76M
EBIT
-182.95M -114.76M
Depreciation & Amortization
-2.37M 39K